[Lenzer 342 — bmj.com] Formindep “promotes independent medical education and information” found that the working groups involved with the guidelines for Alzheimer’s disease had major financial conflicts of interest and some members failed to disclose their financial interests.
It’s fine to demand disclosure of financial interests, but what would they do with the guidelines if they were disclosed? Leave them in the public domain? And what happens if/when the clinical trials underpinning the guidelines were mostly (or wholly) funded by the pharmaceutical industry that seeks to profit from the over-use of prescription drugs?
French guidelines are withdrawn after court finds potential bias among authors
Professor Adam G. Dunn 